4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001415889-24-019610
EVP, R&D AND CSO sold 92,377 shares at an average $7.04 ($650,563)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morisset Valerie EVP, R&D AND CSO | 2024-07-12 | Sale | −50,000 | $7.07 | $353,500 | 294,683 | D |
| Morisset Valerie EVP, R&D AND CSO | 2024-07-15 | Sale | −42,377 | $7.01 | $297,063 | 252,306 | D |
| Open-market sales · 92,377 sh · avg $7.04 · $650,563 | |||||||
Loading xslF345X05/form4-07162024_100734.xml…